Seeking Alpha

Prolor Biotech (PBTH +8.2%) hires Jefferies Group to evaluate strategic alternatives. An unnamed...

Prolor Biotech (PBTH +8.2%) hires Jefferies Group to evaluate strategic alternatives. An unnamed source says the company has drawn interest from big pharma over the past 12 months, but notes PBTH has not decided to sell itself. SA contributor Daniel Lauchheimer's article suggesting the stock has "unlimited upside" looks prescient. (See also: PBTH gets orphan drug designation) 
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector